An Alzheimer’s Blood Test Is Negative but Symptoms Continue: What to Ask

A negative result narrows one cause; use targeted questions and follow-up tests to find what is driving symptoms.

A negative Alzheimer's blood test means amyloid plaques are unlikely, but continuing memory or thinking symptoms still need a follow-up plan. Ask your clinician what test was used, what could have altered it, and what causes will be checked next. These tests measure blood markers, such as the pTau217 to amyloid ratio, to aid detection of Alzheimer's-related amyloid pathology. The FDA cleared Fujirebio's Lumipulse test in May 2025 for adults 55 and older with cognitive decline in specialized care, as described in the FDA clearance summary via Xtalks.

Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.

Table of Contents

How strong is a negative result?

In the 499-patient clearance study, positive results matched amyloid pathology about 92% of the time. Negative predictive value was 97.3%, and about 19.6% of results were indeterminate and needed further testing, as reported in Neuro.wiki's summary of FDA data.

The Alzheimer's Association guideline says triaging tests with at least 90% sensitivity and 75% specificity can rule out Alzheimer's pathology when negative. Positive results should be confirmed with spinal-fluid analysis or amyloid PET, according to the Alzheimer's Association guideline in Alzheimer's and Dementia. FDA labeling also stresses that these are aids, not stand-alone diagnoses.

Could health history change the result?

Yes. Kidney dysfunction, diabetes, high cholesterol, obesity, and some medications can shift plasma biomarker levels. Karolinska Institutet researchers advise reviewing kidney function and current drugs after an unexpected negative.

A history of traumatic brain injury was tied to false-negative results on an FDA-approved amyloid blood test. Medscape reports this as a specific limitation. Mention any concussion, blast exposure, or hospitalization for head injury, even from years ago.

What else can cause these symptoms?

Roche states a negative pTau217 result signals low likelihood of amyloid pathology. That result lets clinicians skip spinal-fluid testing or PET in many cases and refocus on other causes.

Many other conditions produce memory loss, confusion, or behavior change. They still need direct workup, according to Mayo Clinic Press guidance:.

  • vascular disease, Lewy body disease, or frontotemporal dementia
  • thyroid disease, vitamin B12 deficiency, or infection
  • depression, sleep apnea or other sleep disorders
  • medication side effects, alcohol use, or drug interactions

What should you ask next?

Bring a symptom timeline, all prescriptions and supplements, and recent kidney, thyroid, and B12 labs. Ask whether the test was indeterminate, what cutoff was used, and whether repeat testing or another method is warranted.

  • Was my result clearly negative or near the indeterminate range?
  • Do my kidney function, weight, diabetes, cholesterol, or drugs affect this result?
  • Does my head-injury history matter here?
  • Which non-Alzheimer's causes fit my pattern best?
  • Do I need brain imaging, sleep testing, mood testing, or neuropsychological testing next?

You Might Also Like

HelpDementia.com

Dementia, Alzheimer's, Caregiving & Healthy Aging Guidance

© 2026 HelpDementia.com. All rights reserved.

Educational information only. It is not medical advice and does not replace care from a qualified clinician.